ABSTRACT Background: The lack of effective disease-modifying treatments highlights the need for research on the prevention of dementia. It has been suggested that coffee has a protective effect on cognitive performance in old age, but only some of the previous studies have shown this association. Objective: The aim of our study was to analyze the potential association between coffee drinking in middle age and cognitive performance in old age in a large sample of Finnish twins. Design: Coffee consumption and other baseline variables of 2606 middle-aged Finnish twins were assessed in 1975 and 1981 by postal questionnaires. After the median follow-up of 28 y, their cognitive status was measured by using a validated telephone interview questionnaire. Results: Coffee consumption was high and associated with educational level and several other baseline variables. After adjustment for these variables, linear regression analysis showed that coffee consumption was not an independent predictor of cognitive performance in old age (b = 20.12 test score units per coffee cup; 95% CI: 20.27, 0.04). No consistent differences in coffee consumption and cognitive score were observed within discordant twin pairs. Also, coffee drinking did not affect the risk of mild cognitive impairment or dementia. Conclusions: Coffee drinking is associated with many sociodemographic and health variables, but our results do not support an independent role of coffee in the pathogenesis of cognitive decline and dementia.
INTRODUCTION
Alzheimer disease (AD) and vascular disorders are important causes of dementia (1) , although the pathological mechanisms underlying various causes both differ and equate (2) . In addition to age and genetic factors, type 2 diabetes (3), hypertension (4) , and indicators of atherosclerosis, such as coronary and peripheral arterial disease (5) , increase the risk of dementia and its major subtypes, AD and vascular dementia. Because coffee has a beneficial influence on diseases that increase the risk of dementia (6) (7) (8) , it may protect against dementia as well. Besides the antiatherosclerotic mechanisms of coffee, caffeine may affect cognition by blocking the adenosine A2a receptor (9, 10) and increasing intracellular calcium concentrations (11) .
The results of epidemiologic studies concerning coffee consumption and memory impairment are, however, inconsistent. Only 1 of the 2 cross-sectional studies showed that current coffee consumption enhanced cognitive performance (12) , whereas 1 showed that only lifetime coffee consumption had an enhancing effect (13) . A case-control study showed that AD patients consumed less coffee preceding diagnosis than did healthy control subjects (14) . Four prospective studies found that coffee consumption protects against AD (15, 16) and cognitive decline (17, 18) , whereas one concluded that coffee intake does not counteract age-related cognitive decline at baseline (19) or during follow-up (20) .
Genetic and environmental factors play a role in coffee drinking (21) and the pathogenesis of AD (22) . Our aim was to examine whether coffee drinking is associated with cognitive performance in old age and whether coffee drinking protects against cognitive decline within a large sample of Finnish twinpairs.
SUBJECTS AND METHODS

Study population and assessment of dementia
The subjects were recruited from the older cohort of 13,888 like-sexed twin pairs born before 1958 in the Finnish Twin Cohort Study (24) . Zygosity, coffee consumption, and other sociodemographic and health variables were assessed for the first time in 1975 and again in 1981 by postal questionnaires (response rates of 89% and 84%, respectively). The results between zygosity determination based on the questionnaire items (confusion by strangers in childhood and similarity in appearance) and genetic markers were consistent in a subsample (25) .
All twin individuals aged 65 y were asked to participate in a telephone interview to assess their cognitive status. Monozygotic twin individuals with both co-twins alive were inter-viewed between the years 1999 and 2001 and like-sexed dizygotic (DZ) twins and twins of uncertain zygosity (irrespective of the status of their twin sibling) between the years 2003 and 2007. Each subject was sent a letter containing information about the study 1 wk before the interview, and their consent was obtained at the beginning of the phone call. The interviews were carried out by research nurses, who were blinded with respect to any subject's dementia status. The study protocol was approved by the joint Ethical Committee of the University of Turku and the Turku University Central Hospital.
Cognitive status was defined by using a combination of a screen to identify potential dementia cases (TELE) (26) and the Telephone Interview for Cognitive Status (TICS) (27) . Both screens are sensitive and specific and differentiate even patients with mild AD from healthy control subjects and correlate strongly with clinical measurements of cognitive function such as the Mini-Mental State Examination (MMSE) (28) . Questions included in both screens were asked once, and the total score of this 29-item interview formed a linear variable representing cognitive function, which we refer to as the cognitive score. Higher scores indicate better cognitive function.
Subjects were also classified as demented, cognitively declined, and healthy according to their TELE and TICS scores. Maximum scores for these tests are 20 and 33 points, respectively; low scores indicate dementia, and high scores indicate normal memory. The cutoff scores of ,16 for TELE and ,22.5 for TICS were established for dementia, which ensured that the false-positive rate was minimal in the demented category. The cutoff scores of .17.5 for TELE and .26.5 for TICS were established for healthy subjects to minimize the false-negative rate in the group considered to be healthy. The intermediate TELE and TICS scores of 16.0-17.5 and 22.5-26.5, respectively, indicated mild cognitive impairment (28) . On the basis of TELE scores, 445 individuals were found to be demented and 642 were found to be cognitively impaired. On the basis of TICS scores, 345 individuals were found to be demented and 637 were found to be cognitively impaired.
The telephone interview was completed for 2483 twins of known zygosity (703 MZ twins and 1780 DZ twins) and for 123 twins of uncertain zygosity with an overall response rate of 79%. Of those who were not interviewed, 127 were not reached by telephone, 412 declined to participate in the interview, 32 died before being contacted, and 133 were not contacted or their interviews were not completed. For the MZ twins, the participants and nonparticipants were found to be comparable with respect to sex, schooling, and alcohol use (29) . The earliest hospitalization for dementia (International Classification of Disease-9 rubric 290) was in 1993, whereas 3% (68/2483) of the subjects had been prescribed medications (donepezil, galantamine, memantine or rivastigmine) for dementia after 1996, when they became reimbursable by the Social Insurance Institution.
In our sample, 69 subjects were either using psychosis medication or had a physician diagnosis of psychosis, 36 subjects were using epilepsy medication, and 1 subject had a diagnosis of mental retardation based on the medication records of the National Social Insurance Institution. Because these disease states were rare and were not significantly associated with the total score of cognitive score according to linear regression analysis, we also included them in the analyses.
Coffee consumption
Coffee drinking was assessed by the question, "How many cups of coffee do you drink daily?" Respondents who did not drink coffee daily were advised to answer zero. Tea consumption was also assessed by a congruent question in both surveys. Because tea consumption was minimal compared with coffee consumption, and caffeinated soft drinks were not widely consumed in Finland at the time of the surveys, we confined our analysis to coffee consumption.
Of those who completed the telephone interview, 2428 had reported their daily coffee consumption in 1975, 2300 in 1981, and 2172 in both surveys, in which case the mean coffee consumption was calculated; 2556 subjects had reported their daily coffee consumption in at least one survey.
Sociodemographic and lifestyle variables
Education, assessed in 1975 and 1981, was analyzed as a continuous variable (years of education). Respondents were asked to classify themselves in 1 of 8 categories of attained educational level, and this was converted to respond either 3, 6, 7, 9, 10, 12, 13, or 16 y of education. Because cognitive decline and incidence of dementia has been shown to be more strongly associated with binge-drinking pattern than a certain quantity of alcohol consumed (29), we considered binge drinking as a confounding variable. Life satisfaction, assessed with a 4-question scale (30) , and smoking status were based on 1981 questionnaire, or on the 1975 questionnaire if the respondent did not answer these questions in 1981. Body mass index (BMI; in kg/m 2 ) was the average of the subject's BMI in both years or for just 1 y not reported in both years.
Histories of cardiovascular disease, hypercholesterolemia, hypertension, and diabetes were established according to the questionnaires, the Social Insurance Institution's records, and hospital discharge registry records. Access to the records was based on permissions from the appropriate authorities and was carried out by record-linkage using the unique personal identification number assigned to all Finnish citizens in the 1960s. In Finland, medication for these diseases is fully or nearly fully reimbursable. To qualify for reimbursement, a certificate from the treating physician is reviewed by physicians at the Social Insurance Institution and needs to meet specified diagnostic criteria. The register for reimbursed medication is considered to have extensive coverage.
Statistical analyses
Linear regression analysis, adjusted for all of the confounding variables, was used to estimate the association between coffee consumption and other baseline characteristics. Then, the association between cognitive performance at an older age and baseline variables such as coffee consumption was analyzed similarly, and age-adjusted differences in means between sexes were also tested. Adjustments were done first for education, age at the interview, and sex followed by adjustment for all of the confounding variables, which were included as covariates in the model. The odds ratios for dementia and mild cognitive impairment compared with normal cognitive function, in relation to coffee consumption, were estimated by using multinominal logistic regression analyses. Analyses were carried out by using Stata 9.2 for Windows (StataCorp, College Station, TX).
Twins were treated as individuals in all of the aforementioned analyses, although they had been sampled as pairs. The dependence of individual observations (clustering within pairs) was taken into account in all analyses to obtain correct CIs using the cluster option in Stata (31) . Finally, we analyzed the association between cognitive performance and coffee drinking within discordant twin pairs. Because all co-twins were reared together, because MZ twins share all of their genes, and because DZ twins, on average, share half of their segregating genes, an association within twin pairs suggests a real causal effect of coffee consumption on risk of cognitive decline.
RESULTS
Overall, coffee consumption was high: 75% of men and 83% of women consumed .3 cups coffee/d ( 1 cup = 237 mL). Daily coffee consumption was 5.2 cups (95% CI: 5.1, 5.4) in men and 5.3 cups (95% CI: 5.2, 5.5) in women. Only 3.9% of men and 1.4% of women reported no daily coffee consumption. Nevertheless, they could not be considered abstainers because overall coffee consumption was not questioned.
Women drank an average of 0.56 cups more coffee per day than did men (P = 0.002). Linear regression analysis showed that each year of education decreased coffee consumption by 0.17 cups/d (P , 0.001), whereas each unit increase in BMI increased coffee consumption by 0.09 cups/d (P = 0.002). Former and current smokers drank 0.64 (P = 0.002) and 1.4 (P , 0.001) more cups of coffee daily than did those who reported no cigarette smoking in their lifetime, whereas occasional smoking, age at the time of the questionnaire, binge alcohol drinking, life satisfaction, cardiovascular disease, hypercholesterolemia, hypertension, and diabetes were not significantly associated with coffee drinking.
Mean cognitive scores in relation to baseline characteristics separately in men and women and age-adjusted differences in means between sexes are shown in Table 1 . The mean (6 SD) age at the time of the telephone interview was 74.4 6 5.27 y, and 48.0% of the respondents were women.
According to TELE, the prevalences of dementia were 9.8%, 11.9%, 19.1%, 31.7%, and 53.0% in subjects aged 65-69, 70-74, 75-79, 80-84, and .84 y. According to TICS, the response rates were 7.8%, 7.9%, 15.6%, 25.3%, and 47.0%. The association between coffee consumption and decrease in cognitive score was significant only when education was not treated as a confounding variable, when every additional daily cup of coffee drank decreased the total score by 0.27 points. Adjustment for the educational level led to the loss of the significance of this association, whereas each additional year of education increased the cognitive score by an average of 0.72 points (P , 0.001) ( Table 2) .
Each increase in year of age at the time of the questionnaire decreased the cognitive score by 0.46 point (P , 0.001). Sex was not an independent predictor of cognitive score, and, when analyzed separately, coffee consumption was not associated with cognitive score in either men (P = 0.27) or in women (P = 0.62). BMI, life satisfaction, cardiovascular disease, hypertension, and diabetes had a significant effect on cognitive score when adjusted for sex, age at the interview, and educational level, but only the effect of lesser life satisfaction and age at the interview were statistically significant when adjusted for all of the confounding variables. Smoking, binge drinking, and hypercholesterolemia did not affect the cognitive score in our data.
Because the association between coffee consumption and cognitive score was not significant when the whole sample was analyzed, we divided our sample in 2 equal parts according to the year of birth, to test whether this association reached the significance only in the younger subjects, because older subjects are more prone to several diseases that might have led to the decrease in their coffee consumption between the time of questionnaires and telephone interview. Linear regression analysis showed that coffee consumption was not significantly associated with the cognitive score, in either subjects born before We also analyzed whether coffee consumption had a predictive role for mild cognitive impairment or dementia in old age. Subjects were divided into those drinking 0-3, 3.5-8, and .8 cups/d (Table 3 ), and we also tested the categories of 0-3, 3.5-6, and .6 cups/d (data not shown). None of these relative risks were significant, and coffee consumption did not show consistent associations with these clinical categories of cognitive impairment. To test the potential threshold effect of coffee consumption, we analyzed separately whether the consumption of either 1, 2, or 3 cups coffee/d compared with 0 cups coffee/d predicted dementia or mild cognitive impairment. However, none of these more detailed categories had a significant predictive role in either dementia or cognitive impairment (data not shown). Because the last category of coffee consumption (.8 cups/d) contained only those consuming the most coffee (n = 266), we were able to observe any association between coffee drinking and cognitive performance, even if a high threshold of coffee effect existed.
Finally, we performed a twin-pair analysis to observe whether some consistency in the differences in cognitive score and coffee consumption existed within twin pairs discordant for coffee consumption and cognitive score (data not shown). The correlation between the pairwise differences in cognitive score and coffee drinking was 20.05 (95% CI: 20.12, 0.02) among 819 like-sexed pairs, which was not statistically significant and confirmed the results of our previous analyses on individuals. This correlation was similar between MZ and DZ pairs.
DISCUSSION
The main finding of our study was the lack of any association between coffee drinking in middle age and cognitive performance in old age beyond a median follow-up of 28 y. Moreover, the effect of coffee drinking on reductions in cognitive capacity in crude (unadjusted) analyses contradicts the findings of several studies, which suggests that coffee consumption protects against cognitive decline and prevents dementia.
Several circumstances may explain the different results between studies. First, our sample size was larger than most samples. Indeed, the most extensive longitudinal study from France in 7017 subjects aged 65 y followed for an average of 3.5 y found no relation between caffeine intake and cognitive impairment in men (18) . In women from the same study, however, caffeine protected against a decline in 1 of 3 cognitive tests COFFEE AND DEMENTIA 4 Subjects using medications for chronic cardiac insufficiency, with chronic coronary heart disease, with chronic arrhythmias, with familial hypercholesterolemia or related familial dyslipidemia, or with dyslipidemia associated with chronic coronary artery disease, reimbursable by the Social Insurance Institution, or with cardiovascular disease (International Classification of Diseases 8/9 rubric codes 390-399 and 410-449) according to hospital discharge registry before 1996.
5 Subjects who reported in 1981 that their blood cholesterol concentration had been measured during the past 5 y and was considered either low or normal (no) or high (yes).
6 Subjects using medication for chronic hypertension, reimbursable by the Social Insurance Institution, or who reported a physician diagnosis of hypertension in 1975, 1981, or in both years regardless of medication status.
7 Subjects who had diabetes of any type according to Social Insurance Institution medication records, hospital discharge registry, or questionnaire responses classified as described by Kaprio et al (1992) ; 98% of respondents with diabetes had a diagnosis of type 2 diabetes mellitus. but did not reduce the risk of dementia. The next largest prospective study, conducted in 4088 subjects aged 65 y and followed for 5 y, found that coffee consumption protected against AD (15); the study populations were, however, smaller in other studies, except for one cross-sectional survey of 7063 subjects, in which current coffee drinking enhanced the subjects' performance on cognitive tests (12) . Interestingly, in the latter study and 2 other studies (19, 20) , the mean age of the subjects was 52 y, whereas in the other studies, including ours, the subjects were substantially older. Because the smallest study showing a protective effect of coffee consumption comprised only 108 subjects (14) , several smaller unpublished studies in which caffeine failed to protect against cognitive decline may exist.
Second, the present study assessed baseline coffee consumption twice, the median follow-up being 28 y and the mean age of the respondents being 46 y in 1975 and 52 y in 1981 when coffee consumption was assessed. In the latest study from Finland, the average follow-up was 21 y (16), but in the other studies, coffee consumption was assessed either retrospectively (13, 14) , not more than 10 y before cognitive performance measurement (15, 17, 18, 20) , or only the current coffee consumption was assessed (12, 19) . Because our previous study in all subjects in the older cohort of the Finnish Twin Cohort Study showed that the mean intake of coffee was stable over 6 y and a moderate correlation in coffee drinking was observed over the 6-y follow-up period (21), a substantial decrease in coffee drinking by age was not expected. In addition, it is reasonable to assume that only long-term use of a neuroprotective substance would significantly modify the progression of a neurodegenerative disorder such as AD. We were also able to take into account the effect of many confounding variables included inconsistently in the previous COFFEE AND DEMENTIA studies. Nevertheless, education was taken into account in all of the previous studies and thus does not explain their inconsistency. In sum, because all patterns of coffee drinking (from consumption limited to occasional festivities to daily consumption of 10 cups) are represented in Finland, the potential relation between coffee consumption and cognitive performance in older age, if it exists, should be demonstrable in the Finnish population. Increased coffee consumption has been shown to be associated with decreased tea consumption and vice-versa (32, 33) . Indeed, in our study, tea consumption was minimal compared with coffee consumption. In 1975, only 53% of men and 38% of women who answered question concerning tea consumption drank 1 cup tea/d. In 1981, the rate was 60% for men and 53% for women. Among those who reported daily tea drinking, the mean consumption was 2.2 and 1.9 cups/d in 1975 and 2.0 and 1.8 cups in 1981.
Coffee contains a wide range of biologically active substances (34) and cannot be unambiguously compared with any certain amount of tea, although some estimations of their caffeine content exist (35, 36) . Furthermore, no caffeinated soft drinks were widely consumed in Finland at the time of the surveys. Because coffee is a licit and socially accepted beverage, which was widely availably at the time of the postal questionnaires, we consider the reliability of reporting coffee drinking to be high.
Because cognitive performance was estimated at one time point, we were unable to test whether coffee consumption affected the degree or rate of cognitive decline. Nevertheless, because none of the subjects were likely to be demented at the time when coffee consumption was assessed (with the first hospitalization for dementia occurring .10 y after the second assessment), we assumed that the effect of coffee drinking on pathological processes underlying cognitive decline was clear.
The measurement of cognitive performance was sensitive and specific, although telephone interviews used have some limitations (29) . The total score of items from the 2 telephone screens formed a linear variable and allowed us to examine the effect of baseline characteristics on cognitive performance at older ages, instead of merely pure cognitive impairment and dementia incidence. Because cognitive performance was analyzed by using linear variables in all but one of the other studies, measurement of cognitive performance failed to explain the inconsistent results. The relatively high prevalence rates of dementia found in our study cohort reflect the high dementia risk of the Finnish population, which is probably due to the high prevalence of cardiovascular diseases, higher frequency of the apo E4 allele (37) , and low educational level of Finnish elderly. Again, any relation between coffee consumption and cognitive performance in older age should be demonstrable in this high-risk population.
In the previous studies, cognitive status was assessed by using either clinical dementia diagnosis (16) or select cognitive tests. In the latter case, in only one of these studies did coffee consumption enhance the performance of all the tests performed (12) . In this study, however, the mean age was ,50 y. In other studies, the neuroprotective effect of caffeine-containing drinks manifested only in the selected cognitive tests, such as Isaac's test (18) , the motor choice reaction test (19, 20) , the visual verbal learning test (19) , and the MMSE (13), whereas some other tests failed to show this effect. Nevertheless, because no effective disease-modifying clinical treatment of AD exists (38) , the potential role of coffee drinking as a protector against cognitive impairment and dementia has aroused much interest, despite these inconsistent findings.
Onthebasisofthebeneficialeffectofcaffeineonvasculardiseases and the omnipresent role of vascular alterations in dementia, our hypothesis was that caffeine protects against pathological processes underlying cognitive decline and clinical dementia. Indeed, cardiovascular disease, diabetes, and life (dis)satisfaction were found to be significantly associated with lower cognitive performance, which supports the hypothesis of the association between metabolic and vascular alterations and cognitive decline. Nevertheless, on the basis of our study, coffee drinking failed to protect against pathologic processes of cognitive decline and therefore cannot be considered to be protective against dementia.
